Detalles de la búsqueda
1.
Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials.
J Infect Dis
; 217(10): 1616-1625, 2018 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29401325
2.
Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults.
J Infect Dis
; 215(12): 1789-1798, 2017 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28549145
3.
The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials.
Lancet Infect Dis
; 23(5): 621-633, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36682364
4.
A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine.
BMC Infect Dis
; 12: 279, 2012 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-23110320
5.
Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Among Patients With Acute Otitis Externa: A Randomized Clinical Trial.
JAMA Netw Open
; 5(7): e2221699, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35834251
6.
Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults.
Open Forum Infect Dis
; 9(7): ofac206, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35794943
7.
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial.
Lancet Infect Dis
; 22(7): 1062-1075, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35461522
8.
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial.
Nat Med
; 28(5): 1042-1049, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35241844
9.
A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine.
Vaccine
; 39(20): 2791-2799, 2021 05 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33707061
10.
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis.
Nat Med
; 27(11): 2025-2031, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34526698
11.
Evaluating Effectiveness of an Acute Rehabilitation Program in Hospital-Associated Deconditioning.
J Geriatr Phys Ther
; 43(4): 172-178, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31389854
12.
Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial.
Lancet Infect Dis
; 19(6): 631-640, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31079947
13.
Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial.
Vaccine
; 35(10): 1431-1439, 2017 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28187952
14.
Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.
Vaccine
; 35(6): 923-928, 2017 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28089141
15.
Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial.
Vaccine
; 35(35 Pt B): 4621-4628, 2017 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28720281
16.
Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial.
J Pediatric Infect Dis Soc
; 6(1): 9-19, 2017 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28062552
17.
Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trial.
Vaccine
; 33(4): 559-67, 2015 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25448092
Resultados
1 -
17
de 17
1
Próxima >
>>